To the Editor Juo et al1 found that no significant difference was observed between loop ileostomy (LI) and total abdominal colectomy (TAC) for treating fulminant Clostridium difficile colitis (FCDC) in their retrospective cohort study. The overall in-hospital mortality rate for patients undergoing surgery for FCDC was 30.1%, with no significant difference between LI and TAC (26.0% vs 31.1%; P = .28). The findings would be beneficial for patients with FCDC because LI could be less invasive and maintain physiologic functions of colon compared with TAC. However, we are concerned about the higher rates of operative wound disruption (5.6% vs 2.3%; P = .04) and surgical site infection (SSI) (8.9% vs 3.6%; P = .01) among patients receiving LI compared with TAC, which is inconsistent with the prior study2 that showed the lower SSI rate for LI compared with TAC (2.1% vs 10.5%; P < .07).
Identify all potential conflicts of interest that might be relevant to your comment.
Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued.
Err on the side of full disclosure.
If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response.
Not all submitted comments are published. Please see our commenting policy for details.
Kanemoto Y, Kurokawa T, Tanimoto T. Loop Ileostomy a Viable Alternative for Clostridium difficile Colitis? JAMA Surg. Published online November 06, 2019. doi:https://doi.org/10.1001/jamasurg.2019.4698
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: